Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
prodrug activation | conversion of an administered precursor into its active form | Prodrug activation was considered when reviewing the patient's interacting medicines. | Assessment | Medication response, exposure and reconciliation |
protein binding | association of drug with circulating proteins | Altered protein binding limits interpretation of the total concentration alone. | Assessment | Drug levels - exposure and pharmacokinetics |
provisional attribution | tentative assignment of a cause | The provisional attribution to medication exposure will be reconsidered after repeat testing. | Assessment | Diagnostic reasoning and strength of evidence |
rebound concentration | increase after an initial decline owing to redistribution or another cause | The team compared the rebound concentration with the end-of-session measurement. | Assessment | Drug levels - exposure and pharmacokinetics |
rebound congestion | nasal obstruction returning or worsening after repeated topical decongestant use | Rebound congestion was considered from the duration of spray use. | Assessment | Medication response, exposure and reconciliation |
rebound hypertension | increase in blood pressure after interruption of a blood-pressure-lowering therapy | Rebound hypertension was considered after the interrupted regimen was verified. | Assessment | Medication response, exposure and reconciliation |
recall bias | systematic distortion related to remembering past events | The exposure estimate is subject to recall bias because the diary began later. | Assessment | Diagnostic reasoning and strength of evidence |
redistribution | movement of drug between tissues and the sampled compartment | The observed rebound may reflect redistribution after dialysis. | Assessment | Drug levels - exposure and pharmacokinetics |
reduced work hours | working fewer hours because of symptoms or recovery | The patient reports reduced work hours during the first two weeks after discharge. | Subjective | Activities, exposure and recovery history |
relative bioavailability | systemic availability of one preparation compared with a reference preparation | The formulation comparison reports relative bioavailability. | Assessment | Drug concentrations, exposure and assay interpretation |
renal clearance | removal of a drug or analyte by the kidneys | The assessment considers reduced renal clearance after the creatinine increase. | Assessment | Drug levels - exposure and pharmacokinetics |
reporting limit | boundary beyond which the laboratory uses a qualified result | The value is below the reporting limit and is retained with its inequality sign. | Assessment | Drug concentrations, exposure and assay interpretation |
residual error | difference or unexplained variation between observed and model-predicted values | The model review examined residual error across early and late samples. | Assessment | Drug concentrations, exposure and assay interpretation |
residual renal clearance | drug or solute removal by remaining native kidney function | The residual renal clearance was considered alongside extracorporeal removal. | Assessment | Medication response, exposure and reconciliation |
resumption level | concentration measured in relation to restarting an interrupted regimen | The resumption level was interpreted with the date and time therapy resumed. | Assessment | Medication response, exposure and reconciliation |
returned | came back after easing | Reports that the hoarseness returned after a symptom-free week. | Subjective | Sequence, exposures and use of medicines |
rhabdomyolysis | muscle breakdown with release of intracellular contents | The consultant documented rhabdomyolysis using the clinical and laboratory findings. | Assessment | Medication exposure, response and adverse-effect reasoning |
route discrepancy | ordered and documented routes of administration differ | The route discrepancy was resolved by reviewing the original administration record. | Assessment | Medication response, exposure and reconciliation |
saturable metabolism | metabolic capacity becomes limiting as concentration rises | The assessment notes possible saturable metabolism when interpreting the phenytoin trend. | Assessment | Drug levels - exposure and pharmacokinetics |
sedative burden | combined sedating effects of the regimen | The regimen's sedative burden may contribute to daytime drowsiness. | Assessment | Medication exposure, response and adverse-effect reasoning |
| blood testing for antibodies or antigens in context | Obtain the exposure-specific serology requested by infectious diseases. | Plan | Diagnostic procedures and specimen handling | |
side effect | additional effect of treatment described in context | The patient describes dry mouth as the most troublesome side effect. | Assessment | Medication exposure, response and adverse-effect reasoning |
sirolimus | mTOR inhibitor monitored using whole-blood concentrations in specified settings | The sirolimus report states whole blood and the collection time. | Objective | Drug levels - named analytes and exposure reports |
sleep disruption from caregiving | loss of sleep due to providing care for someone else | The patient reports sleep disruption from caregiving on nights when the family member needs assistance. | Subjective | Activities, exposure and recovery history |
social isolation | limited meaningful contact with other people | The patient reports social isolation since transportation became unreliable. | Subjective | Activities, exposure and recovery history |